|
| 37097267 | An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies. | Cytotherapy | 2023 |
| 37517865 | International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. | Cytotherapy | 2023 |
| 34536300 | Hope, hype, cures, and persons with cerebral palsy. | Dev Med Child Neurol | 2022 |
| 35762622 | Stem cells, cell therapies, and bioengineering in lung biology and disease 2021. | Am J Physiol Lung Cell Mol Physiol | 2022 |
| 33082092 | Crowdfunding, stem cell interventions and autism spectrum disorder: comparing campaigns related to an international "stem cell clinic" and US academic medical center. | Cytotherapy | 2021 |
| 34653406 | Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. | Stem Cell Reports | 2021 |
| 34739831 | The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. | Cell Stem Cell | 2021 |
| 34010517 | Ethical issues concerning a pay-to-participate stem cell study. | Stem Cells Transl Med | 2021 |
| 34048692 | ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. | Stem Cell Reports | 2021 |
| 34048693 | ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions. | Stem Cell Reports | 2021 |
| 32319855 | Challenging misinformation and engaging patients: characterizing a regenerative medicine consult service. | Regen Med | 2020 |
| 33023369 | Is right to try being tried? Using crowdfunding data to better understand usage of nontrial pre-approval access pathways. | Regen Med | 2020 |
| 32464095 | Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19. | Cell Stem Cell | 2020 |
| 30782021 | The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments. | Health (London) | 2019 |
| 31237628 | Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell Interventions. | JAMA | 2019 |
| 31491393 | Stem Cell Businesses and Right to Try Laws. | Cell Stem Cell | 2019 |
| 31227615 | Crowdfunding for stem cell-based interventions to treat neurologic diseases and injuries. | Neurology | 2019 |
| 30917290 | Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases. | Ann Am Thorac Soc | 2019 |
| 29239793 | Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions. | Cytotherapy | 2018 |
| 29805145 | The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions. | Perspect Biol Med | 2018 |
| 29801003 | Crowdfunding for Unproven Stem Cell-Based Interventions. | JAMA | 2018 |
| 29934051 | Co-opting of ClinicalTrials.gov by patient-funded studies. | Lancet Respir Med | 2018 |
| 30255734 | Direct-to-consumer marketing of stem cell interventions by Canadian businesses. | Regen Med | 2018 |
| 29985757 | Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns. | Regen Med | 2018 |
| 30258150 | Clear up this stem-cell mess. | Nature | 2018 |
| 31143461 | The stem cell market and policy options: a call for clarity. | J Law Biosci | 2018 |
| 29327974 | The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis. | Regen Med | 2018 |
| 28721755 | ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studies. | Regen Med | 2017 |
| 28129955 | [Primary infection with cytomegalovirus: An infectious cause of splenic infarction]. | Rev Med Interne | 2017 |
| 28621208 | Stem cells in court: historical trends in US legal cases related to stem cells. | Regen Med | 2017 |
| 28532482 | "Ensure that you are well aware of the risks you are taking⿦": actions and activities medical tourists' informal caregivers can undertake to protect their health and safety. | BMC Public Health | 2017 |
| 26719207 | Part 6: The role of communication in better understanding unproven cellular therapies. | Cytotherapy | 2016 |
| 27374789 | Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry. | Cell Stem Cell | 2016 |
| 25939934 | Federal Regulatory Oversight of US Clinics Marketing Adipose-Derived Autologous Stem Cell Interventions: Insights From 3 New FDA Draft Guidance Documents. | Mayo Clin Proc | 2015 |
| 26589750 | Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective. | Cytotherapy | 2015 |
| 26022761 | US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions. | Regen Med | 2015 |
| 25945404 | US stem cell clinics, patient safety, and the FDA. | Trends Mol Med | 2015 |
| 23289812 | Understanding the impacts of medical tourism on health human resources in Barbados: a prospective, qualitative study of stakeholder perceptions. | Int J Equity Health | 2013 |
| 24289231 | Knowledge brokers, companions, and navigators: a qualitative examination of informal caregivers' roles in medical tourism. | Int J Equity Health | 2013 |
| 23889860 | "You're dealing with an emotionally charged individual...": an industry perspective on the challenges posed by medical tourists' informal caregiver-companions. | Global Health | 2013 |
| 23803134 | The OHRP and SUPPORT--another view. | N Engl J Med | 2013 |
| 23396563 | Ethical and legal implications of the risks of medical tourism for patients: a qualitative study of Canadian health and safety representatives' perspectives. | BMJ Open | 2013 |
| 23507179 | Transnational medical travel--ethical dimensions of global healthcare. | Camb Q Healthc Ethics | 2013 |
| 22420449 | News media reports of patient deaths following 'medical tourism' for cosmetic surgery and bariatric surgery. | Dev World Bioeth | 2012 |
| 23634159 | Making Canada a destination for medical tourists: why Canadian provinces should not try to become "Mayo Clinics of the North". | Healthc Policy | 2012 |
| 23224541 | Stem cells. U.S. regulation of stem cells as medical products. | Science | 2012 |
| 22703873 | Beyond "medical tourism": Canadian companies marketing medical travel. | Global Health | 2012 |
| 22499811 | Canada's turbulent medical tourism industry. | Can Fam Physician | 2012 |
| 20621396 | [Chronic cough as the presenting feature of temporal arteritis]. | Rev Med Interne | 2011 |
| 21995598 | Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel. | Global Health | 2011 |